)
Edge6 Mar 2026
Upvoted: The Story of Reddit
How Reddit built a unique platform around communities and conversation, turning human insight and intent into a distinctive business model.
Dicot
Dicot (DICOT) investor relations material
Dicot Q4 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q4 2025 earnings summary18 Feb, 2026
Executive summary
Achieved positive phase 2a results for LIB-01, showing long-acting efficacy and favorable safety in erectile dysfunction, supporting advancement to phase 2b in 2026.
Strengthened scientific understanding of LIB-01's mechanism, highlighting its differentiated action and potential in metabolic diseases.
Signed agreement with a global CRO to prepare for phase 2b clinical trial in the US and Europe.
Financial highlights
Net sales for both Q4 and full year 2025 were MSEK 0.0, unchanged from prior year.
Result after financial items for Q4 was MSEK -16.8 (improved from -20.8), and for the full year MSEK -80.2 (worsened from -57.7).
Earnings per share for Q4 was SEK -0.01 (unchanged), and for the full year SEK -0.04 (improved from -0.05).
Cash and cash equivalents at year-end were SEK 69.2 million, down from SEK 113.4 million.
Market value at year-end was SEK 617 million, up 25% from previous year.
Outlook and guidance
Phase 2b clinical study for LIB-01 is planned to start in the second half of 2026 in the US and Europe.
Focus for 2026 is on initiating phase 2b and evaluating expansion into additional therapeutic areas.
Company will need to strengthen its cash position ahead of phase 2b through equity, out-licensing, or both.
Phase 2b funding strategy and timeline
LIB-01's MoA and new indication focus
How does LIB-01 fit into the longevity market?
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Dicot
- LIB-01's Phase 2a success and strong cash position set the stage for next clinical milestones.DICOT
Q3 202523 Oct 2025 - Phase 2a study enrollment completed; strong cash position supports next development steps.DICOTQ2 202512 Aug 2025
- LIB-01 phase 2a trial fully funded after oversubscribed rights issue; Nasdaq listing approved.DICOTQ3 202413 Jun 2025
- Phase 2a for LIB-01 is fully funded after a 65%-secured SEK 122.6M rights issue.DICOTQ2 202413 Jun 2025
- Strong warrant uptake and robust cash position support ongoing LIB-01 clinical progress.DICOTQ1 20256 Jun 2025
- LIB-01 advanced to phase 2a with robust funding and new US patents, positioning for growth.DICOTQ4 20245 Jun 2025
Next Dicot earnings date
Q1 202630 Apr, 2026
Dicot
Next Dicot earnings date
Q1 202630 Apr, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage